英文别名: |
Norgestrel;Norgestrel [USAN:INN:BAN:JAN];(+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;dl-13-beta-Ethyl-17-alpha-ethynyl-17-beta-hydroxygon-4-en-3-one;dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone;18,19-Dinor-17-alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (+-)-;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-,(17alpha)-(+-)-;Norgestrel (DL-);Levonorgestrel;(±)-Norgestrel;fh122-a;monovar;Neogest;NORPLANT;Ovrette;sh850;wy3707;(17α)-(±)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one;DL-13b-Ethyl-17a-ethynyl-17b-hydroxygon-4-en-3-one;17-beta-Hydroxy-18-methyl-19-nor-17-alpha-pregn-4-en-20-yn-3-one;NSC-744007;Q416950;PORTIA COMPONENT LEVONORGESTREL;13-ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one;Ovoplex 30-150;SH-850;Jadelle;Z1544404028;Wy-5104;ORSYTHIA COMPONENT LEVONORGESTREL;Nordette 28;Microlut;Norgestrelum [INN-Latin];Norgestrel (JP17/USP/INN);TWIRLA COMPONENT LEVONORGESTREL;AFIRMELLE COMPONENT LEVONORGESTREL;LEVONORGESTREL COMPONENT OF CLIMARA PRO;Triquilar ED;(-)-Norgestrel, 98%;13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;Norgestrel [Progestins];13-ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one;Rigevidon 21+7;Levonorgestrel (JAN/USP/INN);Plan B One Step;LEVONORGESTREL COMPONENT OF TWIRLA;CRYSELLE COMPONENT NORGESTREL;Prestwick0_000773;NORGESTREL [EP MONOGRAPH];Prestwick1_000773;(-)-17alpha-Ethynyl-18-methyl-19-nortestosterone;Levonorgestrel [USAN:USP:INN:BAN];NCGC00159349-02;NORGESTREL [MI];TRIVORA COMPONENT LEVONORGESTREL;(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one;BCP9000852;LEVONORGESTREL [WHO-DD];(-)-Levonorgestrel;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(-)-;Triciclor;LEVONORGESTREL [USP-RS];ELIFEMME COMPONENT LEVONORGESTREL;Mirena;Norplant (TN);17alpha-Ethynyl-13-ethyl-19-nortestosterone;BPBio1_000932;LEVONORGESTREL [USP IMPURITY];SR-01000759218-5;Norgestrelum;KYLEENA COMPONENT LEVONORGESTREL;LEVONORGESTREL [JAN];18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-17-HYDROXY-, (17alpha)-(+/-)-;NORGESTREL [HSDB];17alpha-Ethynyl-18-homo-19-nortestosterone;DL Norgestrel;LMST02030119;LEVONORGESTREL COMPONENT OF QUASENSE;BRN 2391114;BAY 86-5028;BAY86-5028;Trinordiol 21;17alpha-Ethynyl-18-homo-19-nor-testosterone;1lhv;NORGESTIMATE IMPURITY B [EP IMPURITY];CCRIS 6525;Opera_ID_552;19-Nortestosterone, 17-ethynyl-18-methyl-;HMS3649J10;MLS000069491;Stediril 30;HMS1570K08;Levonorgestrel for system suitability 1;(+-)-Norgestrel;CCG-100853;PREVEN COMPONENT LEVONORGESTREL;Kyleena;Levonorgestrel implant;HY-B0257;NorLevo;Preven;Ovral-Lo;L-4455;Microgynon CD;D(-)-Norgestrel, analytical standard;Levonelle;Levora-21;Norplant System in Plastic Container;Levonorgestrel, European Pharmacopoeia (EP) Reference Standard;HMS2232K12;Postinor;Nordette 2... |